Orally administered doxycycline accumulates in synovial fluid compared to plasma

Equine Veterinary Journal

Volumn 42, Issue 3, 2010, Pages 208-212

  Schnabel, L V ^a   Papich, M G ^b   Watts, A E ^a   Fortier, L A ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Doxycycline; Horse; MMP; Osteoarthritis; Synovial fluid

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CHEMISTRY; DOSE RESPONSE; HALF LIFE TIME; HORSE; ORAL DRUG ADMINISTRATION; SYNOVIAL FLUID;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HALF-LIFE; HORSES; SYNOVIAL FLUID;

EID: 77953411064     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.2746/042516409X478514     Document Type: Article

References (33)

1. Amin, A.R., Attur, M.G., Thakker, G.D., Patel, P.D., Vyas, P.R., Patel, R.N., Patel, I.R. and Abramson, S.B. (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. USA 24, 14014-14019.
2. Bidgood, T.L. and Papich, M.G. (2003) Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. Am. J. vet. Res. 8, 1040-1046.
3. Borderie, D., Hernvann, A., Hilliquin, P., Lemarchal, H., Kahan, A. and Ekindjian, O.G. (2001) Tetracyclines inhibit nitrosothiol production by cytokine-stimulated osteoarthritic synovial cells. Inflamm. Res. 8, 409-414.
4. Brandt, K.D. and Mazzuca, S.A. (2006) Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. Rheum. Dis. Clin. North Am. 1, 217-234.
5. Brandt, K.D., Mazzuca, S.A., Katz, B.P., Lane, K.A., Buckwalter, K.A., Yocum, D.E., Wolfe, F., Schnitzer, T.J., Moreland, L.W., Manzi, S., Bradley, J.D., Sharma, L., Oddis, C.V., Hugenberg, S.T. and Heck, L.W. (2005) Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 7, 2015-2025.
6. Breedveld, F.C., Dijkmans, B.A. and Mattie, H. (1990) Minocycline treatment for rheumatoid arthritis: an open dose finding study. J. Rheumatol. 1, 43-46.
7. Bryant, J.E., Brown, M.P., Gronwall, R.R. and Merritt, K.A. (2000) Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine vet. J. 3, 233-238.
8. Davis, J.L., Salmon, J.H. and Papich, M.G. (2006) Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. Am. J. vet. Res. 2, 310-316.
9. Ensink, J.M., Van, K.B., Houwers, D.J., Klein, W.R. and Vulto, A.G. (1993) In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine vet. J. 4, 309-313.
10. Fortier, L.A., Motta, T.M., Greenwald, R.A., Divers, T.J. and Mayr, K.G. (2009) Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1α and MMP-13 induced catabolic gene expression responses. J. Orthop. Res. epub 7th October.
11. Gabrielsson, J. and Weiner, D. (2000) Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts & Applications, 3rd edn., Apotekarsocieteten, Stockholm. pp 1-924.
12. Gilmour, M.A., Clarke, C.R., Macallister, C.G., Dedeo, J.M., Caudell, D.L., Morton, R.J. and Pugh, M. (2005) Ocular penetration of oral doxycycline in the horse. Vet. Ophthalmol. 5, 331-335.
13. Golub, L.M., Ramamurthy, N.S., McNamara, T.F., Greenwald, R.A. and Rifkin, B.R. (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 3, 297-321.
14. Hogenmiller, M.S. and Lozada, C.J. (2006) An update on osteoarthritis therapeutics. Curr. Opin. Rheumatol. 3, 256-260.
15. Lees, P., Svendsen, O. and Wiuff, C. (2008) Strategies to minimize the impact of antimicrobial treatment on the selection of resistant bacteria. In: Guide to Antimicrobial Use in Animals, Eds: L. Guardabassi, L.B. Jensen and H. Kruse Wiley-Blackwell, Oxford. pp 77-101.
16. Nordstrom, D., Lindy, O., Lauhio, A., Sorsa, T., Santavirta, S. and Konttinen, Y.T. (1998) Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol. Int. 5, 175-180.
17. Pardy, C.K., Matyas, J.R. and Zernicke, R.F. (2004) Doxycycline effects on mechanical and morphometrical properties of early- and late-stage osteoarthritic bone following anterior cruciate ligament injury. J. appl. Physiol. 4, 1254-1260.
18. Pruzanski, W., Greenwald, R.A., Street, I.P., Laliberte, F., Stefanski, E. and Vadas, P. (1992) Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem. Pharmacol. 6, 1165-1170.
19. Ramamurthy, N.S., Rifkin, B.R., Greenwald, R.A., Xu, J.W., Liu, Y., Turner, G., Golub, L.M. and Vernillo, A.T. (2002) Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J. Periodontol. 7, 726-734.
20. Ryan, M.E., Greenwald, R.A. and Golub, L.M. (1996) Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr. Opin. Rheumatol. 3, 238-247.
21. Sadowski, T. and Steinmeyer, J. (2001) Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Inflamm. Res. 3, 175-182.
22. Saivin, S. and Houin, G. (1988) Clinical pharmacokinetics of doxycycline and minocycline. Clin. Pharmacokinet. 6, 355-366.
23. Sapadin, A.N. and Fleischmajer, R. (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. 2, 258-265.
24. Shlopov, B.V., Stuart, J.M., Gumanovskaya, M.L. and Hasty, K.A. (2001) Regulation of cartilage collagenase by doxycycline. J. Rheumatol. 4, 835-842.
25. Smieja, M., MacPherson, D.W., Kean, W., Schmuck, M.L., Goldsmith, C.H., Buchanan, W., Hart, L.E. and Mahony, J.B. (2001) Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis. Ann. Rheum. Dis. 12, 1088-1094.
26. Smith, Jr., G.N., Yu, Jr., L.P., Brandt, K.D. and Capello, W.N. (1998) Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J. Rheumatol. 3, 532-535.
27. Sreekanth, V.R., Handa, R., Wali, J.P., Aggarwal, P. and Dwivedi, S.N. (2000) Doxycycline in the treatment of rheumatoid arthritis - a pilot study. J. Ass. Physicians India 8, 804-807.
28. Stone, M., Fortin, P.R., Pacheco-Tena, C. and Inman, R.D. (2003) Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J. Rheumatol. 10, 2112-2122.
29. Tilley, B.C., Alarcon, G.S., Heyse, S.P., Trentham, D.E., Neuner, R., Kaplan, D.A., Clegg, D.O., Leisen, J.C., Buckley, L., Cooper, S.M., Duncan, H., Pillemer, S.R., Tuttleman, M. and Fowler, S.E. (1995) Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann. Intern. Med. 2, 81-89.
30. Van Der Laan, W., Molenaar, E., Ronday, K., Verheijen, J., Breedveld, F., Greenwald, R., Dijkmans, B. and TeKoppele, J. (2001) Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. J. Rheumatol. 9, 1967-1974.
31. Yu, Jr., L.P., Smith, Jr., G.N., Hasty, K.A. and Brandt, K.D. (1991) Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase. J. Rheumatol. 10, 1450-1452.
32. Yu, Jr., L.P., Burr, D.B., Brandt, K.D., O'Connor, B.L., Rubinow, A. and Albrecht, M. (1996) Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. J. Rheumatol. 1, 137-142.
33. Yu, Jr., L.P., Smith, Jr., G.N., Brandt, K.D., Myers, S.L., O'Connor, B.L. and Brandt, D.A. (1992) Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum. 10, 1150-1159.